Vitamin C and the common cold.
The effect of vitamin C on the common cold has been the subject of several studies. These studies do not support a considerable decrease in the incidence of the common cold with supplemental vitamin C. However, vitamin C has consistently decreased the duration of cold episodes and the severity of symptoms. The benefits that have been observed in different studies show a large variation and, therefore, the clinical significance may not be clearly inferred from them. The biochemical explanation for the benefits may be based on the antioxidant property of vitamin C. In an infection, phagocytic leucocytes become activated and they produce oxidizing compounds which are released from the cell. By reacting with these oxidants, vitamin C may decrease the inflammatory effects caused by them. Scurvy, which is caused by a deficiency in vitamin C, is mostly attributed to the decreased synthesis of collagen. However, vitamin C also participates in several other reactions, such as the destruction of oxidizing substances. The common cold studies indicate that the amounts of vitamin C which safely protect from scurvy may still be too low to provide an efficient rate for other reactions, possibly antioxidant in nature, in infected people.
Hemilä
H
H
Institute of Biotechnology, University of Helsinki, Finland.
D000975:Antioxidants / Q000493:pharmacokinetics; D001205:Ascorbic Acid / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D002986:Clinical Trials as Topic; D003139:Common Cold / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D006633:Histamine Antagonists / Q000494:pharmacology; D006801:Humans; D009504:Neutrophils / Q000502:physiology; D010587:Phagocytosis / Q000187:drug effects; D013997:Time Factors
D000975:Antioxidants; D006633:Histamine Antagonists; D001205:Ascorbic Acid